Jack A. Khattar - Net Worth and Insider Trading
Jack A. Khattar Net Worth
The estimated net worth of Jack A. Khattar is at least $56 Million dollars as of 2024-04-27. Jack A. Khattar is the President, CEO of Supernus Pharmaceuticals Inc and owns about 1,851,972 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $56 Million. Jack A. Khattar is also the Director of scPharmaceuticals Inc and owns about 5,000 shares of scPharmaceuticals Inc (SCPH) stock worth over $22,450. Details can be seen in Jack A. Khattar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jack A. Khattar has not made any transactions after 2023-02-03 and currently still holds the listed stock(s).
Transaction Summary of Jack A. Khattar
Jack A. Khattar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jack A. Khattar owns 4 companies in total, including Supernus Pharmaceuticals Inc (SUPN) , scPharmaceuticals Inc (SCPH) , and Tesaro Inc (TSRO) among others .
Click here to see the complete history of Jack A. Khattar’s form 4 insider trades.
Insider Ownership Summary of Jack A. Khattar
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SUPN | Supernus Pharmaceuticals Inc | 2023-02-03 | director & President & CEO |
| SCPH | scPharmaceuticals Inc | 2021-12-03 | director |
| TSRO | Tesaro Inc | 2016-03-29 | director & President & CEO |
| CGTX | Cognition Therapeutics Inc | 2022-06-10 | director |
Jack A. Khattar Latest Holdings Summary
Jack A. Khattar currently owns a total of 2 stocks. Among these stocks, Jack A. Khattar owns 1,851,972 shares of Supernus Pharmaceuticals Inc (SUPN) as of February 3, 2023, with a value of $56 Million and a weighting of 99.96%. Jack A. Khattar also owns 5,000 shares of scPharmaceuticals Inc (SCPH) as of December 3, 2021, with a value of $22,450 and a weighting of 0.04%.
Latest Holdings of Jack A. Khattar
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SUPN | Supernus Pharmaceuticals Inc | 2023-02-03 | 1,851,972 | 30.07 | 55,688,798 |
| SCPH | scPharmaceuticals Inc | 2021-12-03 | 5,000 | 4.49 | 22,450 |
Holding Weightings of Jack A. Khattar
Jack A. Khattar Form 4 Trading Tracker
According to the SEC Form 4 filings, Jack A. Khattar has made a total of 16 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years, including 1 buys and 15 sells. The most-recent trade in Supernus Pharmaceuticals Inc is the sale of 13,732 shares on February 3, 2023, which brought Jack A. Khattar around $577,431.
According to the SEC Form 4 filings, Jack A. Khattar has made a total of 1 transactions in scPharmaceuticals Inc (SCPH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in scPharmaceuticals Inc is the acquisition of 5,000 shares on December 3, 2021, which cost Jack A. Khattar around $19,550.
Insider Trading History of Jack A. Khattar
- 1
Jack A. Khattar Trading Performance
GuruFocus tracks the stock performance after each of Jack A. Khattar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jack A. Khattar is 32.9%. GuruFocus also compares Jack A. Khattar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jack A. Khattar within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jack A. Khattar's insider trading performs compared to the benchmark.
Performance of Jack A. Khattar
Average Return
33.27%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.57 | 32.9 | 31.35 | 33.27 | 19.68 | 26.29 |
| Relative Return to S&P 500(%) | 0.67 | 30.1 | 26.55 | 22.04 | 5.17 | 13.73 |
Jack A. Khattar Ownership Network
Ownership Network List of Jack A. Khattar
Ownership Network Relation of Jack A. Khattar
Jack A. Khattar Owned Company Details
What does Supernus Pharmaceuticals Inc do?
Who are the key executives at Supernus Pharmaceuticals Inc?
Jack A. Khattar is the director & President & CEO of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , Sr. V.P. & Regulatory Affairs Tami Tillotson Martin , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .
Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary
Over the past 18 months, Jack A. Khattar made 10 insider transaction in Supernus Pharmaceuticals Inc (SUPN) with a net sale of 76,390. Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 116,005 shares made by Padmanabh P. Bhatt , a net sale of 21,235 shares made by Tami Tillotson Martin , and a net sale of 5,890 shares made by Frank Mottola .
In summary, during the past 3 months, insiders sold 98,505 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 98,505 shares. During the past 18 months, 231,113 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 231,113 shares.
Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Supernus Pharmaceuticals Inc Insider Transactions
Jack A. Khattar Mailing Address
Above is the net worth, insider trading, and ownership report for Jack A. Khattar. You might contact Jack A. Khattar via mailing address: C/o Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
